Descartes reported Q1FY27 revenue of $193.6m, up 15% year over year, with a 46% Adjusted EBITDA margin. It closed the Idelic acquisition for about $25.3m net cash and expanded share repurchases under an NCIB. The results highlight strong cash flow, a growing AI-enabled GLN, and upside from strategic investments.
Strong top-line growth, solid profitability, and accretive acquisition could lift DSGX valuation; buybacks signal management confidence.
Bullish over the next 6–12 months on growth, accretion from Idelic, and capital returns.
Category: Earnings. The release centers on quarterly results and non-GAAP Adjusted EBITDA, with a strategic acquisition and capital returns that may drive longer-term value.